Citius Pharmaceuticals (CTXR) Minority Interest (2020 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Minority Interest came in at $7.5 million in Q1 2026, up 158.64% YoY from $2.9 million in Q1 2025, and down 44.17% on a QoQ basis from $13.5 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Minority Interest (2020 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 7 years of Minority Interest data on file, last reported at $7.5 million in Q1 2026.
- Quarterly Minority Interest rose 158.64% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 158.64% YoY) and the FY2025 annual result came in at $10.0 million, up 147.92% from the prior year.
- Minority Interest declined to $7.5 million in Q1 2026, from $13.5 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $13.5 million in Q4 2025 to a low of $600380.0 in Q1 2022.
- A 5-year average of $2.9 million and a median of $600380.0 in 2022 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2022 — Minority Interest changed 0.0% — and 2024, when it surged 570.31%.
- Tracing CTXR's Minority Interest over 5 years: stood at $600380.0 in 2022, then changed by 0.0% to $600380.0 in 2023, then jumped by 484.86% to $3.5 million in 2024, then soared by 284.74% to $13.5 million in 2025, then plunged by 44.17% to $7.5 million in 2026.
- The last three Minority Interest figures came in at $7.5 million (Q1 2026), $13.5 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Citius Pharmaceuticals | 15.60 Mn | 15.60 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.54 Mn |
| Dec 31, 2025 | 13.51 Mn |
| Sep 30, 2025 | 9.98 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | 600,380.00 |
| Mar 31, 2024 | 600,380.00 |
| Dec 31, 2023 | 600,380.00 |
| Sep 30, 2023 | 600,380.00 |
| Jun 30, 2023 | 600,380.00 |
| Mar 31, 2023 | 600,380.00 |
| Dec 31, 2022 | 600,380.00 |
| Sep 30, 2022 | 600,380.00 |
| Jun 30, 2022 | 600,380.00 |
| Mar 31, 2022 | 600,380.00 |
| Dec 31, 2021 | 600,380.00 |
| Sep 30, 2021 | 600,380.00 |
| Jun 30, 2021 | 600,380.00 |